CCO Oncology Podcast

189 Episoder

1. Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

   Publisert: 7.5.2024
2. Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer

   Publisert: 28.3.2024
3. Real-world Perspectives on Novel HER2-Targeted and TROP-2–Directed Therapies in Advanced Breast Cancer

   Publisert: 18.3.2024
4. Current Considerations for Adverse Event Management With HER3-Directed Agents

   Publisert: 26.12.2023
5. Unpacking the Potential of HER3-Targeted Therapy in NSCLC

   Publisert: 26.12.2023
6. Recent Advances in ADCs and Rationale for HER3 as a Target in Lung Cancer

   Publisert: 26.12.2023
7. Expert Insight on Seminal New Clinical Trial Data Presented at the 2023 IGCS Conference Informing Treatment for Endometrial, Ovarian, and Cervical Cancers

   Publisert: 4.12.2023
8. Novel Emerging Investigational Treatment Strategies for Patients With Myelofibrosis

   Publisert: 30.11.2023
9. A Year in Review and a Look to the Future: BTKi in CLL and MCL

   Publisert: 20.11.2023
10. Expert Insight on Key Updates and New Clinical Trial Data From the ESMO 2023 Congress Informing Treatment for Endometrial, Ovarian, and Cervical Cancers

    Publisert: 17.11.2023
11. Expert Insights and Considerations for Precision Care With HER3-Targeted Agents in NSCLC and Breast Cancer

    Publisert: 7.11.2023
12. Improving Care for Black Patients With Endometrial Cancer

    Publisert: 6.11.2023
13. Expert Insight on Key Updates and New Clinical Trial Data From the ESGO 2023 Congress Informing Treatment for Cervical, Ovarian, and Endometrial Cancers

    Publisert: 13.10.2023
14. New Evidence With BTK Inhibitor Therapy in CLL and MCL From SOHO 2023

    Publisert: 4.10.2023
15. New Evidence With BTK Inhibitor Therapy in MCL From ICML 2023

    Publisert: 17.8.2023
16. New Evidence With BTK Inhibitor Therapy in CLL From EHA 2023

    Publisert: 28.7.2023
17. Expert Insight on Key Updates and New Clinical Trial Data From the 2023 ASCO Annual Meeting, Informing Treatment for Cervical, Ovarian, and Endometrial Cancers

    Publisert: 22.6.2023
18. Expert Insight on New Data From SGO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian Cancers

    Publisert: 4.5.2023
19. Practical Insights on Using BCMA-Targeted Therapies in Multiple Myeloma

    Publisert: 26.4.2023
20. Contemporary Approaches to Treating Myelofibrosis: A Conversation Between Experts

    Publisert: 11.4.2023